跳至主要内容
临床试验/NCT00399061
NCT00399061已完成4 期

Efficacy of Optive Versus Systane Concomitant With Restasis (Cyclosporine A) for the Treatment of Dry Eye Symptoms

Innovative Medical1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2006年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
55
试验地点
1
主要终点
Efficacy

研究概览

简要总结

The purpose of this study is to evaluate the efficacy of Optive versus Systane used concomitantly with topical cyclosporine for the treatment of dry eye.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • · Males or females > 18 years old
  • Score of at least 2 and no more than 4 on the SESOD at the initial screening visit (mild to severe patients)
  • At least Grade 2 conjunctival staining
  • Likely to complete all study visits and able to provide informed consent

排除标准

  • · Prior unsuccessful use of topical cyclosporine (defined as patients taking it at least 3 months and saw no improvements)
  • Current use of topical cyclosporine
  • Known contraindications to any study medication or ingredients
  • Female of child bearing potential not using reliable methods of birth control, or pregnant or lactating females.
  • Planned use of contact lenses (unless discontinued use ³ 30 days prior to randomization)
  • Active ocular diseases or uncontrolled systemic disease (blepharitis patients that are actively being treated or disease that is uncontrollable)
  • Ocular surgery within the past 3 months,
  • Active ocular allergies

研究组 & 干预措施

1

Active Comparator

Systane

干预措施: Systane, Optive, Restasis (Drug)

2

Active Comparator

Optive

干预措施: Systane, Optive, Restasis (Drug)

3

Placebo Comparator

Restasis

干预措施: Systane, Optive, Restasis (Drug)

结局指标

主要结局

Efficacy

时间窗: 1 yr 3 months

次要结局

  • Dry eye symptoms(1yr 3 months)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验